Frontlight ResearchEarly access
Trial site
Pisa
- 5running trials
- 9closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- Stroke3 trials
- Lung cancer2 trials
- Chronic spontaneous urticaria1 trial
- Familial hypercholesterolaemia1 trial
- Hidradenitis suppurativa1 trial
- High blood pressure1 trial
- Metastatic breast cancer1 trial
- Multiple sclerosis1 trial
- Myeloproliferative neoplasms1 trial
- Neuroendocrine tumours1 trial
- Prostate cancer1 trial
- and 1 more
- Phase
- Phase 37 trials
- Phase 22 trials
- Status
- Completed8 trials
- Active, not recruiting4 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals14 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hidradenitis suppurativa1 recruiting
Closed trials
Completed
Completed
Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy
Completed
Completed
Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026